Introduction to the NULISA Technology

Join Alamar Biosciences for an enlightening session where we will delve into captivating case studies and explore how the sensitivity of the NULISA technology is used for Biomarkers Discovery and Clinical Development.

Discover the latest breakthroughs and innovative approaches using NULISA, an ultra-high sensitivity proteomic platform measuring proteins down to a level of fg/ml in multiplex format. This cutting-edge technology holds the promise of advancing and transforming our understanding, as well as finding new treatments for different disease conditions.
Don’t miss this opportunity to engage with experts from Alamar Biosciences and be part of the journey towards a brighter future in medical research.
 

Agenda:

13:00-13:20

Introduction to the NULISA Technology: A new ultra-sensitive proteomics platform for profiling low abundant fluid-based biomarkers
Sandra Kyrk. Regional Business Manager, Nordics & Southern Europe, Alamar Biosciences.

13:20-13:45

Pushing the Limits of its Sensitivity and Multiplexing: NULISA for Biomarkers Discovery and Clinical Development. Case studies
Olga Surova, PhD. Field Application Scientist, EMEA, Alamar Biosciences

13:45-14:00

Closing remarks and Q&A

14:00-15:00

Networking con aperitivo
 

REGISTRATION: https://alamarbio.com/alamar-at-santiago-de-compostela/

Please register to attend this seminar.